# pathway_0165: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0165.txt)

**Task:** `pathway`  
**Author key, unchanged:** **C** — Secondary metabolite biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MNDFVFSDIPDILKPMASVEFDDPLTKATGDVLNWTLWLIRNFPALSNIIMRLPSSLVSIVTSSFEGANQMFQVTTSTHNLYSASLPTHATKQIISKLVEHEKTHIGPKNKDCVVQRLLNAHRDSESKISIPTPDATVRSEAIGFTLAGTADPPNILALGTFMAARDPEMQEGLYKELRAVWPDLRSPVPSYNLLHQLPLLRGVVKESIRFTHGVATGPARLVGAGGARIGGYNVPAKASLAVVAAPSYFVHMDETVFSEPEKFEPRRWADNDYSKSLVAFSRGRRMCPAEQFHVEPYETTSVPRSEERG

[Multiple Choices]
A. terpenoid biosynthesis. .
B. LPS O-antigen biosynthesis. .
C. Secondary metabolite biosynthesis. .
D. Cofactor biosynthesis
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated as cytochrome P450 monooxygenase ppzG, with the pathway listed as secondary metabolite biosynthesis. The annotation cites a paper on pyrrolopyrazine-producing biosynthetic gene clusters; this supports C as the assigned pathway, though the excerpts do not independently establish the experimental basis of the assignment.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A sequence-based recognition of a cytochrome P450 would suggest a monooxygenase, but that enzyme class occurs in multiple kinds of pathways and does not identify this protein's particular pathway.


**Missing item-specific fact**

> The protein-specific fact that ppzG is associated with a pyrrolopyrazine biosynthetic gene cluster and annotated to secondary metabolite biosynthesis.


**Reason**

> That pathway assignment is supported by reviewer-only records, but the supplied sequence and choices do not provide a reliable way to infer this particular P450's pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "C",
  "D"
]
```

> Without the protein-specific pathway annotation, a P450 sequence alone does not distinguish secondary-metabolite biosynthesis from other pathways that can use P450 enzymes, including terpenoid or cofactor biosynthesis. The choices are broad categories, and the input supplies no pathway context.


### Important caveats

- The reviewer-only annotation matches the supplied sequence; it was not available to the evaluated model.
- The cited pathway assignment is database evidence linked to a publication, not independent verification of the underlying experiments here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A sequence-based recognition of a cytochrome P450 would suggest a monooxygenase, but that enzyme class occurs in multiple kinds of pathways and does not identify this protein's particular pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific fact that ppzG is associated with a pyrrolopyrazine biosynthetic gene cluster and annotated to secondary metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by reviewer-only records, but the supplied sequence and choices do not provide a reliable way to infer this particular P450's pathway."
  },
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as cytochrome P450 monooxygenase ppzG, with the pathway listed as secondary metabolite biosynthesis. The annotation cites a paper on pyrrolopyrazine-producing biosynthetic gene clusters; this supports C as the assigned pathway, though the excerpts do not independently establish the experimental basis of the assignment."
  },
  "important_caveats": [
    "The reviewer-only annotation matches the supplied sequence; it was not available to the evaluated model.",
    "The cited pathway assignment is database evidence linked to a publication, not independent verification of the underlying experiments here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "C",
      "D"
    ],
    "reason": "Without the protein-specific pathway annotation, a P450 sequence alone does not distinguish secondary-metabolite biosynthesis from other pathways that can use P450 enzymes, including terpenoid or cofactor biosynthesis. The choices are broad categories, and the input supplies no pathway context."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as cytochrome P450 monooxygenase ppzG, with the pathway listed as secondary metabolite biosynthesis. The annotation cites a paper on pyrrolopyrazine-producing biosynthetic gene clusters; this supports C as the assigned pathway, though the excerpts do not independently establish the experimental basis of the assignment.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A sequence-based recognition of a cytochrome P450 would suggest a monooxygenase, but that enzyme class occurs in multiple kinds of pathways and does not identify this protein's particular pathway.",
    "missing_item_specific_fact": "The protein-specific fact that ppzG is associated with a pyrrolopyrazine biosynthetic gene cluster and annotated to secondary metabolite biosynthesis.",
    "reason": "That pathway assignment is supported by reviewer-only records, but the supplied sequence and choices do not provide a reliable way to infer this particular P450's pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "C", "D"],
    "reason": "Without the protein-specific pathway annotation, a P450 sequence alone does not distinguish secondary-metabolite biosynthesis from other pathways that can use P450 enzymes, including terpenoid or cofactor biosynthesis. The choices are broad categories, and the input supplies no pathway context."
  },
  "important_caveats": [
    "The reviewer-only annotation matches the supplied sequence; it was not available to the evaluated model.",
    "The cited pathway assignment is database evidence linked to a publication, not independent verification of the underlying experiments here."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A455ZM03 (sequence matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence ECO:0000305|PubMed:30452111). The protein is a Cytochrome P450 monooxygenase ppzG, part of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus. Pyrrolopyrazine is a fungal alkaloid secondary metabolite, consistent with the annotation.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could potentially recognize cytochrome P450-like sequence features (degenerate heme-binding motifs, conserved P450 domains) and eliminate option B (LPS O-antigen biosynthesis is exclusively bacterial). However, fungal P450s participate in terpenoid biosynthesis (A), secondary metabolite biosynthesis (C), and cofactor biosynthesis (D). The sequence alone does not reveal the substrate identity (pyrrolopyrazine, an alkaloid) needed to distinguish A from C or C from D.


**Missing item-specific fact**

> The specific substrate/product of this P450 (pyrrolopyrazine, a non-terpenoid alkaloid secondary metabolite) and its membership in the ppz biosynthetic gene cluster. Without knowing the exact protein identity or its biosynthetic cluster context, the pathway assignment among A, C, and D cannot be resolved from sequence features alone.


**Reason**

> While P450 identification from sequence is feasible, the pathway question requires knowing which specific class of metabolite this P450 modifies. Fungal P450s are ubiquitous across terpenoid, alkaloid, polyketide, and cofactor pathways. Distinguishing 'terpenoid biosynthesis' from 'secondary metabolite biosynthesis' for a given P450 requires knowledge of the substrate, which is an item-specific annotation fact absent from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "C"
]
```

> From sequence alone, a fungal P450 could plausibly be assigned to terpenoid biosynthesis (A) since fungal terpenoid pathways employ P450 tailoring enzymes, or to secondary metabolite biosynthesis (C) as the broader category. Without substrate information, both A and C are defensible pathway assignments for a fungal P450. Option D (cofactor biosynthesis) is less likely but not impossible for a P450.


### Important caveats

- The UniProt pathway annotation (ECO:0000305) is based on literature (PubMed:30452111) identifying ppzG within the pyrrolopyrazine BGC, not solely on sequence similarity.
- The sequence-match confirms the protein is A0A455ZM03, but this identification itself is a lookup operation unavailable to the evaluated model.
- Terpenoids are a subclass of secondary metabolites; the question treats them as mutually exclusive categories, which is a simplification of the biochemical taxonomy.
- The reviewer evidence is annotation-based; the underlying experimental evidence (gene knockout, metabolite analysis) is referenced but not independently verified here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could potentially recognize cytochrome P450-like sequence features (degenerate heme-binding motifs, conserved P450 domains) and eliminate option B (LPS O-antigen biosynthesis is exclusively bacterial). However, fungal P450s participate in terpenoid biosynthesis (A), secondary metabolite biosynthesis (C), and cofactor biosynthesis (D). The sequence alone does not reveal the substrate identity (pyrrolopyrazine, an alkaloid) needed to distinguish A from C or C from D.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific substrate/product of this P450 (pyrrolopyrazine, a non-terpenoid alkaloid secondary metabolite) and its membership in the ppz biosynthetic gene cluster. Without knowing the exact protein identity or its biosynthetic cluster context, the pathway assignment among A, C, and D cannot be resolved from sequence features alone.",
    "reason": "While P450 identification from sequence is feasible, the pathway question requires knowing which specific class of metabolite this P450 modifies. Fungal P450s are ubiquitous across terpenoid, alkaloid, polyketide, and cofactor pathways. Distinguishing 'terpenoid biosynthesis' from 'secondary metabolite biosynthesis' for a given P450 requires knowledge of the substrate, which is an item-specific annotation fact absent from the input."
  },
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZM03 (sequence matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence ECO:0000305|PubMed:30452111). The protein is a Cytochrome P450 monooxygenase ppzG, part of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus. Pyrrolopyrazine is a fungal alkaloid secondary metabolite, consistent with the annotation."
  },
  "important_caveats": [
    "The UniProt pathway annotation (ECO:0000305) is based on literature (PubMed:30452111) identifying ppzG within the pyrrolopyrazine BGC, not solely on sequence similarity.",
    "The sequence-match confirms the protein is A0A455ZM03, but this identification itself is a lookup operation unavailable to the evaluated model.",
    "Terpenoids are a subclass of secondary metabolites; the question treats them as mutually exclusive categories, which is a simplification of the biochemical taxonomy.",
    "The reviewer evidence is annotation-based; the underlying experimental evidence (gene knockout, metabolite analysis) is referenced but not independently verified here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "C"
    ],
    "reason": "From sequence alone, a fungal P450 could plausibly be assigned to terpenoid biosynthesis (A) since fungal terpenoid pathways employ P450 tailoring enzymes, or to secondary metabolite biosynthesis (C) as the broader category. Without substrate information, both A and C are defensible pathway assignments for a fungal P450. Option D (cofactor biosynthesis) is less likely but not impossible for a P450."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A455ZM03 (sequence matched) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' (evidence ECO:0000305|PubMed:30452111). The protein is a Cytochrome P450 monooxygenase ppzG, part of the pyrrolopyrazine biosynthetic gene cluster in Metarhizium majus. Pyrrolopyrazine is a fungal alkaloid secondary metabolite, consistent with the annotation.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could potentially recognize cytochrome P450-like sequence features (degenerate heme-binding motifs, conserved P450 domains) and eliminate option B (LPS O-antigen biosynthesis is exclusively bacterial). However, fungal P450s participate in terpenoid biosynthesis (A), secondary metabolite biosynthesis (C), and cofactor biosynthesis (D). The sequence alone does not reveal the substrate identity (pyrrolopyrazine, an alkaloid) needed to distinguish A from C or C from D.",
    "missing_item_specific_fact": "The specific substrate/product of this P450 (pyrrolopyrazine, a non-terpenoid alkaloid secondary metabolite) and its membership in the ppz biosynthetic gene cluster. Without knowing the exact protein identity or its biosynthetic cluster context, the pathway assignment among A, C, and D cannot be resolved from sequence features alone.",
    "reason": "While P450 identification from sequence is feasible, the pathway question requires knowing which specific class of metabolite this P450 modifies. Fungal P450s are ubiquitous across terpenoid, alkaloid, polyketide, and cofactor pathways. Distinguishing 'terpenoid biosynthesis' from 'secondary metabolite biosynthesis' for a given P450 requires knowledge of the substrate, which is an item-specific annotation fact absent from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "C"],
    "reason": "From sequence alone, a fungal P450 could plausibly be assigned to terpenoid biosynthesis (A) since fungal terpenoid pathways employ P450 tailoring enzymes, or to secondary metabolite biosynthesis (C) as the broader category. Without substrate information, both A and C are defensible pathway assignments for a fungal P450. Option D (cofactor biosynthesis) is less likely but not impossible for a P450."
  },
  "important_caveats": [
    "The UniProt pathway annotation (ECO:0000305) is based on literature (PubMed:30452111) identifying ppzG within the pyrrolopyrazine BGC, not solely on sequence similarity.",
    "The sequence-match confirms the protein is A0A455ZM03, but this identification itself is a lookup operation unavailable to the evaluated model.",
    "Terpenoids are a subclass of secondary metabolites; the question treats them as mutually exclusive categories, which is a simplification of the biochemical taxonomy.",
    "The reviewer evidence is annotation-based; the underlying experimental evidence (gene knockout, metabolite analysis) is referenced but not independently verified here."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a pyrrolopyrazine-biosynthesis cluster protein. The annotation cites a paper reporting function and pathway, although these excerpts do not independently establish the experimental details.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may support recognizing an enzyme family, but family-level knowledge alone does not identify this enzyme's pathway: related enzyme families can participate in several of the offered pathways. The sequence contains no clear pathway-specific context here to distinguish secondary-metabolite biosynthesis from the other plausible biosynthetic categories.


**Missing item-specific fact**

> The protein's specific assignment to the pyrrolopyrazine biosynthetic cluster, and thus to secondary metabolite biosynthesis.


**Reason**

> The key depends on the particular pathway role assigned to this protein. That role is not supplied in the sequence or choices, and general enzyme-family knowledge does not meaningfully resolve the pathway among the offered alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched source annotation specifically places this protein in secondary metabolite biosynthesis; the alternatives do not provide a competing pathway assignment supported by the supplied evidence.


### Important caveats

- The pathway support is a database annotation citing a publication, not an independently reviewed experimental result in the supplied excerpts.
- The reviewer-only source matches the provided sequence, but its accession and annotations were not part of the original input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may support recognizing an enzyme family, but family-level knowledge alone does not identify this enzyme's pathway: related enzyme families can participate in several of the offered pathways. The sequence contains no clear pathway-specific context here to distinguish secondary-metabolite biosynthesis from the other plausible biosynthetic categories.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific assignment to the pyrrolopyrazine biosynthetic cluster, and thus to secondary metabolite biosynthesis.",
    "reason": "The key depends on the particular pathway role assigned to this protein. That role is not supplied in the sequence or choices, and general enzyme-family knowledge does not meaningfully resolve the pathway among the offered alternatives."
  },
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a pyrrolopyrazine-biosynthesis cluster protein. The annotation cites a paper reporting function and pathway, although these excerpts do not independently establish the experimental details."
  },
  "important_caveats": [
    "The pathway support is a database annotation citing a publication, not an independently reviewed experimental result in the supplied excerpts.",
    "The reviewer-only source matches the provided sequence, but its accession and annotations were not part of the original input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched source annotation specifically places this protein in secondary metabolite biosynthesis; the alternatives do not provide a competing pathway assignment supported by the supplied evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the pathway as secondary metabolite biosynthesis and identifies the protein as a pyrrolopyrazine-biosynthesis cluster protein. The annotation cites a paper reporting function and pathway, although these excerpts do not independently establish the experimental details.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may support recognizing an enzyme family, but family-level knowledge alone does not identify this enzyme's pathway: related enzyme families can participate in several of the offered pathways. The sequence contains no clear pathway-specific context here to distinguish secondary-metabolite biosynthesis from the other plausible biosynthetic categories.",
    "missing_item_specific_fact": "The protein's specific assignment to the pyrrolopyrazine biosynthetic cluster, and thus to secondary metabolite biosynthesis.",
    "reason": "The key depends on the particular pathway role assigned to this protein. That role is not supplied in the sequence or choices, and general enzyme-family knowledge does not meaningfully resolve the pathway among the offered alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched source annotation specifically places this protein in secondary metabolite biosynthesis; the alternatives do not provide a competing pathway assignment supported by the supplied evidence."
  },
  "important_caveats": [
    "The pathway support is a database annotation citing a publication, not an independently reviewed experimental result in the supplied excerpts.",
    "The reviewer-only source matches the provided sequence, but its accession and annotations were not part of the original input."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation (evidence C5, H3) explicitly assigns the PATHWAY as 'Secondary metabolite biosynthesis' with evidence code ECO:0000305|PubMed:30452111, based on experimental characterization of ppzG as a cytochrome P450 monooxygenase in the pyrrolopyrazine biosynthetic gene cluster of Metarhizium majus. Pyrrolopyrazine is an alkaloid secondary metabolite, consistent with the pathway assignment.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The C-terminal region contains a recognizable cytochrome P450 heme-binding motif (F...G...R...C pattern in 'FVHMDETVFSEPEKFEPRRWADNDYSKSLVAFSRGRRMCPAEQFHVEPYETTSVPRSEERG'), identifying this as a P450 monooxygenase. The N-terminal hydrophobic stretch is consistent with ER membrane anchoring typical of eukaryotic P450s. Transferable knowledge from many fungal P450s (e.g., in Aspergillus, Fusarium, Claviceps) establishes that fungal P450s are overwhelmingly assigned to secondary metabolite biosynthesis (alkaloid, polyketide, NRPS modification pathways). This pattern strongly favors C. Choice B (LPS O-antigen biosynthesis) is eliminable because LPS is exclusively bacterial and P450s are not part of O-antigen assembly. Choice A (terpenoid biosynthesis) is a narrower subcategory requiring specific terpene-synthase-associated context not evident here. Choice D (cofactor biosynthesis) is possible but far less common for fungal P450s than secondary metabolite roles.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A model can identify the P450 heme-binding motif from the sequence, recognize eukaryotic/fungal character from composition and membrane-anchor features, and apply the well-established empirical pattern that fungal P450s predominantly function in secondary metabolite biosynthesis. This meaningfully distinguishes C from B (bacterial pathway) and provides a probabilistic preference over A and D.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> While terpenoids are technically a subclass of secondary metabolites, in pathway database taxonomy 'terpenoid biosynthesis' and 'secondary metabolite biosynthesis' are listed as distinct categories. Without specific terpenoid-pathway context (e.g., proximity to terpene synthases, specific terpenoid-modifying features), the general 'secondary metabolite biosynthesis' label is the more defensible assignment for a fungal P450. The other options (B, D) are clearly eliminable.


### Important caveats

- The P450 heme-binding motif is recognizable but the protein is shorter (310 aa) than typical P450s (400-600 aa), which may reduce confidence in motif identification from sequence alone.
- The pathway annotation in UniProt is based on genomic context (biosynthetic gene cluster membership) and functional characterization from a single publication (PubMed:30452111), not extensive biochemical validation.
- The distinction between 'terpenoid biosynthesis' (A) and 'secondary metabolite biosynthesis' (C) depends on pathway database taxonomy conventions; in some ontologies terpenoids fall under secondary metabolites.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The C-terminal region contains a recognizable cytochrome P450 heme-binding motif (F...G...R...C pattern in 'FVHMDETVFSEPEKFEPRRWADNDYSKSLVAFSRGRRMCPAEQFHVEPYETTSVPRSEERG'), identifying this as a P450 monooxygenase. The N-terminal hydrophobic stretch is consistent with ER membrane anchoring typical of eukaryotic P450s. Transferable knowledge from many fungal P450s (e.g., in Aspergillus, Fusarium, Claviceps) establishes that fungal P450s are overwhelmingly assigned to secondary metabolite biosynthesis (alkaloid, polyketide, NRPS modification pathways). This pattern strongly favors C. Choice B (LPS O-antigen biosynthesis) is eliminable because LPS is exclusively bacterial and P450s are not part of O-antigen assembly. Choice A (terpenoid biosynthesis) is a narrower subcategory requiring specific terpene-synthase-associated context not evident here. Choice D (cofactor biosynthesis) is possible but far less common for fungal P450s than secondary metabolite roles.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A model can identify the P450 heme-binding motif from the sequence, recognize eukaryotic/fungal character from composition and membrane-anchor features, and apply the well-established empirical pattern that fungal P450s predominantly function in secondary metabolite biosynthesis. This meaningfully distinguishes C from B (bacterial pathway) and provides a probabilistic preference over A and D."
  },
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation (evidence C5, H3) explicitly assigns the PATHWAY as 'Secondary metabolite biosynthesis' with evidence code ECO:0000305|PubMed:30452111, based on experimental characterization of ppzG as a cytochrome P450 monooxygenase in the pyrrolopyrazine biosynthetic gene cluster of Metarhizium majus. Pyrrolopyrazine is an alkaloid secondary metabolite, consistent with the pathway assignment."
  },
  "important_caveats": [
    "The P450 heme-binding motif is recognizable but the protein is shorter (310 aa) than typical P450s (400-600 aa), which may reduce confidence in motif identification from sequence alone.",
    "The pathway annotation in UniProt is based on genomic context (biosynthetic gene cluster membership) and functional characterization from a single publication (PubMed:30452111), not extensive biochemical validation.",
    "The distinction between 'terpenoid biosynthesis' (A) and 'secondary metabolite biosynthesis' (C) depends on pathway database taxonomy conventions; in some ontologies terpenoids fall under secondary metabolites."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While terpenoids are technically a subclass of secondary metabolites, in pathway database taxonomy 'terpenoid biosynthesis' and 'secondary metabolite biosynthesis' are listed as distinct categories. Without specific terpenoid-pathway context (e.g., proximity to terpene synthases, specific terpenoid-modifying features), the general 'secondary metabolite biosynthesis' label is the more defensible assignment for a fungal P450. The other options (B, D) are clearly eliminable."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0165",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation (evidence C5, H3) explicitly assigns the PATHWAY as 'Secondary metabolite biosynthesis' with evidence code ECO:0000305|PubMed:30452111, based on experimental characterization of ppzG as a cytochrome P450 monooxygenase in the pyrrolopyrazine biosynthetic gene cluster of Metarhizium majus. Pyrrolopyrazine is an alkaloid secondary metabolite, consistent with the pathway assignment.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The C-terminal region contains a recognizable cytochrome P450 heme-binding motif (F...G...R...C pattern in 'FVHMDETVFSEPEKFEPRRWADNDYSKSLVAFSRGRRMCPAEQFHVEPYETTSVPRSEERG'), identifying this as a P450 monooxygenase. The N-terminal hydrophobic stretch is consistent with ER membrane anchoring typical of eukaryotic P450s. Transferable knowledge from many fungal P450s (e.g., in Aspergillus, Fusarium, Claviceps) establishes that fungal P450s are overwhelmingly assigned to secondary metabolite biosynthesis (alkaloid, polyketide, NRPS modification pathways). This pattern strongly favors C. Choice B (LPS O-antigen biosynthesis) is eliminable because LPS is exclusively bacterial and P450s are not part of O-antigen assembly. Choice A (terpenoid biosynthesis) is a narrower subcategory requiring specific terpene-synthase-associated context not evident here. Choice D (cofactor biosynthesis) is possible but far less common for fungal P450s than secondary metabolite roles.",
    "missing_item_specific_fact": "",
    "reason": "A model can identify the P450 heme-binding motif from the sequence, recognize eukaryotic/fungal character from composition and membrane-anchor features, and apply the well-established empirical pattern that fungal P450s predominantly function in secondary metabolite biosynthesis. This meaningfully distinguishes C from B (bacterial pathway) and provides a probabilistic preference over A and D."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "While terpenoids are technically a subclass of secondary metabolites, in pathway database taxonomy 'terpenoid biosynthesis' and 'secondary metabolite biosynthesis' are listed as distinct categories. Without specific terpenoid-pathway context (e.g., proximity to terpene synthases, specific terpenoid-modifying features), the general 'secondary metabolite biosynthesis' label is the more defensible assignment for a fungal P450. The other options (B, D) are clearly eliminable."
  },
  "important_caveats": [
    "The P450 heme-binding motif is recognizable but the protein is shorter (310 aa) than typical P450s (400-600 aa), which may reduce confidence in motif identification from sequence alone.",
    "The pathway annotation in UniProt is based on genomic context (biosynthetic gene cluster membership) and functional characterization from a single publication (PubMed:30452111), not extensive biochemical validation.",
    "The distinction between 'terpenoid biosynthesis' (A) and 'secondary metabolite biosynthesis' (C) depends on pathway database taxonomy conventions; in some ontologies terpenoids fall under secondary metabolites."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A455ZM03",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "f43c07841a6175c125bba9ab5474c67719d466b07295c69b50449f964246f483",
  "benchmark_sequence_length": 310,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 24,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2019-06-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "current_source_sequence_sha256": "f43c07841a6175c125bba9ab5474c67719d466b07295c69b50449f964246f483",
  "current_source_sequence_length": 310,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 23,
  "selected_historical_version": {
    "accession": "A0A455ZM03",
    "database": "Swiss-Prot",
    "entryVersion": 23,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "PPZG_METMF",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "c85f65dda2bcec72e8a4991649c1744c4a28fefbb47fb8a716a368c7f84e8a6b",
  "selected_historical_source_sequence_sha256": "f43c07841a6175c125bba9ab5474c67719d466b07295c69b50449f964246f483",
  "selected_historical_source_sequence_length": 310,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 23,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A455ZM03\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":24,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2019-06-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"DAC76723.1\",\"source\":\"EMBL\"}],\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Clavicipitaceae\",\"Metarhizium\",\"Metarhizium majus\"],\"scientificName\":\"Metarhizium majus (strain ARSEF 297)\",\"taxonId\":1276143}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Pyrrolopyrazine biosynthesis cluster protein G\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Cytochrome P450 monooxygenase ppzG\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"30452111\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A455ZM03.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A455ZM03.json",
  "source_sha256": "9c7ce8707b3aae4d0d2f246c70997c160f3bd908218c3af7dd5563094728f4d3",
  "retrieved_utc": "2026-11-02T04:25:17.796999+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Berry D.\",\"Mace W.\",\"Rehner S.A.\",\"Grage K.\",\"Dijkwel P.P.\",\"Young C.A.\",\"Scott B.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"30452111\"},{\"database\":\"DOI\",\"id\":\"10.1111/1462-2920.14483\"}],\"citationType\":\"journal article\",\"firstPage\":\"928\",\"id\":\"30452111\",\"journal\":\"Environ. Microbiol.\",\"lastPage\":\"939\",\"publicationDate\":\"2019\",\"title\":\"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\",\"volume\":\"21\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"ARSEF 297\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23",
  "source_sha256": "c85f65dda2bcec72e8a4991649c1744c4a28fefbb47fb8a716a368c7f84e8a6b",
  "retrieved_utc": "2026-11-02T04:25:20.024616+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   PPZG_METMF              Reviewed;         310 AA.\nAC   A0A455ZM03;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-JUN-2019, sequence version 1.\nDT   28-JAN-2026, entry version 23.\nDE   RecName: Full=Cytochrome P450 monooxygenase ppzG {ECO:0000303|PubMed:30452111};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:30452111};\nDE   AltName: Full=Pyrrolopyrazine biosynthesis cluster protein G {ECO:0000303|PubMed:30452111};\nGN   Name=ppzG;\nOS   Metarhizium majus (strain ARSEF 297).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Clavicipitaceae; Metarhizium;\nOC   Metarhizium majus.\nOX   NCBI_TaxID=1276143 {ECO:0000312|EMBL:DAC76723.1};\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23",
  "source_sha256": "c85f65dda2bcec72e8a4991649c1744c4a28fefbb47fb8a716a368c7f84e8a6b",
  "retrieved_utc": "2026-11-02T04:25:20.024616+00:00",
  "source_locator": "lines 15-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRC   STRAIN=ARSEF 297;\nRX   PubMed=30452111; DOI=10.1111/1462-2920.14483;\nRA   Berry D., Mace W., Rehner S.A., Grage K., Dijkwel P.P., Young C.A.,\nRA   Scott B.;\nRT   \"Orthologous peramine and pyrrolopyrazine-producing biosynthetic gene\nRT   clusters in Metarhizium rileyi, Metarhizium majus and Cladonia grayi.\";\nRL   Environ. Microbiol. 21:928-939(2019).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A455ZM03?format=txt&versions=23",
  "source_sha256": "c85f65dda2bcec72e8a4991649c1744c4a28fefbb47fb8a716a368c7f84e8a6b",
  "retrieved_utc": "2026-11-02T04:25:20.024616+00:00",
  "source_locator": "lines 53-54",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000305|PubMed:30452111}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 165. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
